- Home
- INBX
INBX
Inhibrx Inc.
as of 12-12-2025 3:35pm EST
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
| Founded: | 2010 | Country: | United States |
| Employees: | N/A | City: | LA JOLLA |
| Market Cap: | 430.2M | IPO Year: | 2020 |
| Target Price: | N/A | AVG Volume (30 days): | 236.0K |
| Analyst Decision: | Hold | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -10.03 | EPS Growth: | N/A |
| 52 Week Low/High: | $10.80 - $94.47 | Next Earning Date: | 11-14-2025 |
| Revenue: | $1,400,000 | Revenue Growth: | -19.26% |
| Revenue Growth (this year): | 563% | Revenue Growth (next year): | 230.77% |
AI-Powered INBX Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Inhibrx Inc. (INBX)
10% Owner
Avg Cost/Share
$32.25
Shares
350,000
Total Value
$11,287,500.00
Owned After
1,267,823
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | INBX | 10% Owner | Oct 7, 2025 | Sell | $32.25 | 350,000 | $11,287,500.00 | 1,267,823 |
Compare INBX vs Leading Stocks
See how INBX stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "INBX Inhibrx Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.